Breakthrough AI Tool Uncovers Mechanisms of Drug Action Against Tuberculosis
Tuberculosis (TB) has long stood as one of the most formidable adversaries in the realm of infectious diseases, taking more...
Iris M. reports on pharmacology and drug discovery, tracking therapeutic targets, preclinical findings, clinical candidates, safety signals, and new treatment strategies.
Tuberculosis (TB) has long stood as one of the most formidable adversaries in the realm of infectious diseases, taking more...
In the rapidly evolving landscape of drug discovery, the ability to predict drug–target interactions (DTIs) has emerged as a pivotal...
In a groundbreaking development promising to reshape therapeutic strategies for autoimmune diseases, Tianfu Wu, an associate professor of biomedical engineering...
Imagine a wound dressing that transcends the conventional role of mere coverage and protection to become an intelligent, multifunctional platform—one...
In a groundbreaking advancement in the field of hepatology and inflammatory disease treatment, researchers have uncovered a novel small molecule...
In the constant quest to enhance the safety and efficacy of pharmaceuticals, a team of researchers from Stanford Medicine has...
University of Oregon bioengineer Calin Plesa has pioneered a groundbreaking technology that revolutionizes how biological datasets are generated. This advancement...
In an innovative stride within the realms of pharmaceutical research and drug design, scientists at the Southwest Research Institute (SwRI)...
Boston University’s Chobanian & Avedisian School of Medicine has secured a significant five-year funding award of $2.1 million from the...
In the relentless pursuit of safer and more effective pharmaceuticals, understanding the intricate dance of drug metabolism has always stood...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine